@article{article, title  = {{Venglustat, a novel glucosylceramide synthase inhibitor, in patients at risk of rapidly progressing ADPKD: primary results of a double-blind, placebo-controlled, phase 2/3 randomized clinical trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2022}},

 month = {{12}},

 author = {{Gansevoort RT and Hariri A and Minini P and Ahn C and Chapman AB and Horie S and Knebelmann B and Mrug M and Ong ACM and Pei YPC and Torres VE et al}},

 doi = {{10.1053/j.ajkd.2022.10.016}},

 journal = {{American Journal of Kidney Diseases}},

 note = {{Accessed on 2024/12/22}}}